Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1984 Jan;43(1):432–434. doi: 10.1128/iai.43.1.432-434.1984

Relationship between host age and persistence of Theiler's virus in the central nervous system of mice.

C M Steiner, E J Rozhon, H L Lipton
PMCID: PMC263454  PMID: 6317571

Abstract

This study has demonstrated that the ability of BeAn 8386 virus to persist in the central nervous system of mice declines with the increasing age of the host at the time of inoculation. Although persistent infection was established in 1-, 3-, 9-, and 40-week-old mice, there was a significant reduction in both the frequency of virus isolations and the mean virus titers in mice inoculated after 3 weeks of age. The incidence of clinical demyelinating disease (late disease) also decreased in animals infected after 3 weeks of age in parallel with the decline in virus persistence.

Full text

PDF
434

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DEAN D. J. Mouse encephalomyelitis; immunologic studies of a non-infected colony. J Immunol. 1951 Mar;66(3):347–359. [PubMed] [Google Scholar]
  2. Detels R., Brody J. A., McNew J., Edgar A. H. Further epidemiological studies of subacute sclerosing panencephalitis. Lancet. 1973 Jul 7;2(7819):11–14. doi: 10.1016/s0140-6736(73)91946-6. [DOI] [PubMed] [Google Scholar]
  3. Dhib-Jalbut S. S., Abdelnoor A. M., Haddad F. S. Cellular and humoral immunity in subacute sclerosing panencephalitis. Infect Immun. 1981 Jul;33(1):34–42. doi: 10.1128/iai.33.1.34-42.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lehrich J. R., Arnason B. G., Hochberg F. H. Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci. 1976 Oct;29(2-4):149–160. doi: 10.1016/0022-510x(76)90167-2. [DOI] [PubMed] [Google Scholar]
  5. Lipton H. L., Dal Canto M. C. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci. 1976 Nov;30(1):201–207. doi: 10.1016/0022-510x(76)90267-7. [DOI] [PubMed] [Google Scholar]
  6. Lipton H. L., Dal Canto M. C. Theiler's virus-induced demyelination: prevention by immunosuppression. Science. 1976 Apr 2;192(4234):62–64. doi: 10.1126/science.176726. [DOI] [PubMed] [Google Scholar]
  7. Lipton H. L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun. 1975 May;11(5):1147–1155. doi: 10.1128/iai.11.5.1147-1155.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rabinowitz S. G., Lipton H. L. Cellular immunity in chronic Theiler's virus central nervous system infection. J Immunol. 1976 Aug;117(2):357–363. [PubMed] [Google Scholar]
  9. Roos R. P., Firestone S., Wollmann R., Variakojis D., Arnason B. G. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol. 1982 Jun;2(3-4):223–234. doi: 10.1016/0165-5728(82)90057-1. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES